2004 - Publication Archives

Ballon D, Watts R, Dyke JP, Lis E, Morris MJ, Scher HI, Ulug AM, Jakubowski AA. Imaging therapeutic response in human bone marrow using rapid whole-body MRI. Magn Reson Med. 2004 Dec;52(6):1234-8. PubMedID=15562475

Bertram CD, Timmer J, Muller TG, Maiwald T, Winterhalder M, Voss HU. Aperiodic flow-induced oscillations of collapsible tubes: a critical reappraisal. Med Eng Phys. 2004 Apr;26(3):201-14. PubMedID=14984842

Crystal RG, Sondhi D, Hackett NR, Kaminsky SM, Worgall S, Stieg P, Souweidane M, Hosain S, Heier L, Ballon D, Dinner M, Wisniewski K, Kaplitt M, Greenwald BM, Howell JD, Strybing K, Dyke J, Voss H. Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis. Hum Gene Ther. 2004 Nov;15(11):1131-54. PubMedID=15610613

Goldsmith SJ, Kostakoglu LA, Somrov S, Palestro CJ. Radionuclide imaging of thoracic malignancies. Thorac Surg Clin. 2004 Feb;14(1):95-112. PubMedID=15382313

Goldsmith SJ. Improving insight into radiobiology and radionuclide therapy. J Nucl Med. 2004 Jul;45(7):1104-5. PubMedID=15235053

Hoang BH, Dyke JP, Koutcher JA, Huvos AG, Mizobuchi H, Mazza BA, Gorlick R, Healey JH. VEGF expression in osteosarcoma correlates with vascular permeability by dynamic MRI. Clin Orthop Relat Res. 2004 Sep;(426):32-8. PubMedID=15346048

Konishi S, Hamacher K, Vallabhajosula S, Kothari P, Bastidas D, Bander N, Goldsmith S. Determination of immunoreactive fraction of radiolabeled monoclonal antibodies: what is an appropriate method? Cancer Biother Radiopharm. 2004 Dec;19(6):706-15. PubMedID=15665617

Kostakoglu L, Leonard JP, Coleman M, Goldsmith SJ. The role of FDG-PET imaging in the management of lymphoma. Clin Adv Hematol Oncol. 2004 Feb;2(2):115-21. PubMedID=16163171

Kostakoglu L, Hardoff R, Mirtcheva R, Goldsmith SJ. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics. 2004 Sep-Oct;24(5):1411-31. PubMedID=15371617

Kostakoglu L, Goldsmith SJ. PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus. J Nucl Med. 2004 Jan;45(1):56-68. PubMedID=14734674

Milowsky MI, Nanus DM, Kostakoglu L, Vallabhajosula S, Goldsmith SJ, Bander NH. Phase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancer. J Clin Oncol. 2004 Jul 1;22(13):2522-31. PubMedID=15173215

Pucar D, Koutcher JA, Shah A, Dyke JP, Schwartz L, Thaler H, Kurhanewicz J, Scardino PT, Kelly WK, Hricak H, Zakian KL. Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse. Clin Prostate Cancer. 2004 Dec;3(3):174-81. PubMedID=15636684

Rossberg AG, Bartholomé K, Voss HU, Timmer J. Phase synchronization from noisy univariate signals. Phys Rev Lett. 2004 Oct 8;93(15):154103. PubMedID=15524883

Vallabhajosula S, Smith-Jones PM, Navarro V, Goldsmith SJ, Bander NH. Radioimmunotherapy of prostate cancer in human xenografts using monoclonal antibodies specific to prostate specific membrane antigen (PSMA): studies in nude mice. Prostate. 2004 Feb 1;58(2):145-55. PubMedID=14716739